DR Congo Approves Use Of Experimental Ebola Vaccine; Current Outbreak Subsiding, Officials Say

Nature: Ebola vaccine approved for use in ongoing outbreak
“Regulatory and ethics-review boards in the Democratic Republic of the Congo (DRC) have approved the use of an experimental Ebola vaccine to combat an ongoing outbreak of the virus, officials announced on 29 May. If they decide to deploy the vaccine, called rVSV-ZEBOV, health care workers will offer it to those at highest risk of contracting the disease…” (Maxmen, 5/30).

NPR: Powerful New Ebola Vaccine Heads To Congo To Help Stop Outbreak
“…The outbreak already shows signs of slowing down. There hasn’t been a new confirmed case since May 11. And several suspected cases were ruled out last week…” (Doucleff, 5/30).

U.N. News Centre: DR Congo approves Ebola vaccine to counter outbreak; U.N.-trained volunteers to educate local populations
“To contain the latest outbreak of the Ebola virus in the Democratic Republic of Congo (DRC), the United Nations Children’s Fund (UNICEF) provided technical support to 145 volunteers of the Congolese Red Cross and community health workers to deliver lifesaving information to local populations in remote areas along the Central African Republic border…” (5/30).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.